Metformin also suppressed dipeptidyl peptidase-4 (DPP-4) inhibitor-induced EMT via the suppression of mechanistic target of rapamycin (mTOR) signaling in breast cancer [70]. The gene discussed is DPP4; the disease is breast cancer.